亿帆医药：截至2025年三季报 公司医药制剂产品过亿元人民币收入有10个

Core Viewpoint - Yifan Pharmaceutical reported that by the third quarter of 2025, the company expects to have ten pharmaceutical formulation products generating over 100 million RMB in revenue [2] Group 1 - As of the third quarter of 2025, the company anticipates ten products will exceed 100 million RMB in revenue [2] - The company will disclose the annual revenue of its main products in accordance with relevant laws and regulations [2]